Replay | State of Play, Congress' Ambitious Drug Price Agenda

07/30/19 03:33PM EDT

REPLAY | State of Play | Congress' Ambitious Drug Price Agenda

Healthcare & Health Policy SubscribersCLICK HERE for video & audio replays.

(For unccoperative browers, cut and past: https://app.hedgeye.com/feed_items/76718)

On July 30, Macro Policy analyst, J.T. Taylor and I recapped the state of play for Congressional efforts to reform drug price policy in the US.

In this brief call, we went through:

Introduction:17 -2:47

Major Themes: 2:47 - 6:27

Drug Prices: 6.27 - 10:41

White House Position 10:41-12:24

CBO Scores: 12:24 - 13:15

Changes to Part D Benefit Design 13:16 - 16:15

Impact of Changes to Part D Benefit Design: 16:16-18:10

Part D Price Increase History: 18:12 - 19:07

Part B Drug Increases: 19:07-19:52

Lobbyist Positions: 19:53-22:35

What to Watch: 22:35-26:26

Comments from JT Taylor: 26:26-30:51

Q & A: 30:52-26:21

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.